Mrunal Deepak Barbhai

Mrunal Deepak Barbhai

Auto-generated profile, based on publicly available information

Mrunal Deepak Barbhai

Chemical and Biochemical Processing Division

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2022 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
ASAnshu Sharma
Anshu Sharma
RSRuchi Sharma
Ruchi Sharma
MSMunisha Sharma
Munisha Sharma
Manoj KumarManoj Kumar
Manoj Kumar
MBMrunal Deepak Barbhai
Mrunal Deepak Barbhai
Mohamed MekhemarMohamed Mekhemar
Mohamed Mekhemar
The prevalence of viral infections, cancer, and diabetes is increasing at an alarming rate around the world, and these diseases are now considered to be the most serious risks to human well-being in the modern period. There is a widespread practice in Asian countries of using papaya leaves (C. papaya L.) as herbal medicine, either alone or in combination with prescribed medications, to treat a variety of ailments. The importance of conducting the necessary descriptive studies in order to determine the safety of papaya leaf consumption is also emphasized in the context of their application in the healthcare sector. Electronic databases such as Google Scholar, Scopus, and PubMed were used to gather information on papaya leaves, their therapeutic potential, and clinical evidence-based studies. The literature was gathered from publications on papaya leaves, their therapeutic potential, and clinical evidence-based studies. The antidengue, anticancer, antidiabetic, neuroprotective, and anti-inflammatory effects of papaya leaves discussed in this article are supported by evidence from preclinical, in vivo, in vitro, and clinical trial studies, as well as from other sources. Leaves have been investigated for their mechanism of action as well as their potential to be used in the development of novel herbal products for the health business. According to the reports gathered, only a small number of research demonstrated that leaf extract at high concentrations was hazardous to certain organs. The collective literature reviewed in this review provides insights into the use of papaya leaves as a cure for epidemic diseases, highlighting the phytochemical composition and pharmacological attributes of papaya leaves, as well as the results of various preclinical and clinical studies that have been conducted so far on the subject. The review clearly demonstrates the successful medical evidence for the use of papaya leaf extracts in the healthcare system as a supplemental herbal medication in a variety of clinical settings.

1 January 2022 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
MAMohammed M Alshehri
Mohammed M Alshehri
CQCristina Quispe
Cristina Quispe
JHJesús Herrera
Jesús Herrera
Javad Sharifi-RadJavad Sharifi-Rad
Javad Sharifi-Rad
STSena Tutuncu
Sena Tutuncu
William C. ChoWilliam C. Cho
William C. Cho
The use of phytochemicals is gaining interest for the treatment of metabolic syndromes over the synthetic formulation of drugs. Senna is evolving as one of the important plants which have been vastly studied for its beneficial effects. Various parts of Senna species including the root, stem, leaves, and flower are found rich in numerous phytochemicals. In vitro, in vivo, and clinical experiments established that extracts from Senna plants have diverse beneficial effects by acting as a strong antioxidant and antimicrobial agent. In this review, Senna genus is comprehensively discussed in terms of its botanical characteristics, traditional use, geographic presence, and phytochemical profile. The bioactive compound richness contributes to the biological activity of Senna plant extracts. The review emphasizes on the in vivo and in vitro antioxidant and anti‐infectious properties of the Senna plant. Preclinical studies confirmed the beneficial effects of the Senna plant extracts and its bioactive components in regard to the health‐promoting activities. The safety, side effects, and therapeutic limitations of the Senna plant are also discussed in this review. Additional research is necessary to utilize the phenolic compounds towards its use as an alternative to pharmacological treatments and even as an ingredient in functional foods.


11 May 2022 in Food Hydrocolloids
Verified
Journal Article
Closed access
Manoj KumarManoj Kumar
Manoj Kumar
PSPavidharshini Selvasekaran
Pavidharshini Selvasekaran
SKSwati Kapoor
Swati Kapoor
MBMrunal D. Barbhai
Mrunal D. Barbhai
JLJosé M. Lorenzo
José M. Lorenzo
JKJohn F. Kennedy
John F. Kennedy

14 October 2023 in TrAC Trends in Analytical Chemistry
Verified
Journal Article
Closed access
Manoj KumarManoj Kumar
Manoj Kumar
MBMrunal Deepak Barbhai
Mrunal Deepak Barbhai
SPShriniketan Puranik
Shriniketan Puranik
RRRadha Radha
Radha Radha
SNSUMAN NATTA
SUMAN NATTA
Jose Manuel LorenzoJose Manuel Lorenzo
Jose Manuel Lorenzo

30 December 2021 in Journal of Nanomaterials
Verified
Journal Article
Open access
PDF file
Pankaj Kumar TyagiPankaj Kumar Tyagi
Pankaj Kumar Tyagi
CQCristina Quispe
Cristina Quispe
JHJesús Herrera
Jesús Herrera
STShruti Tyagi
Shruti Tyagi
DMD. Barbhai Mrunal
D. Barbhai Mrunal
SRSeema Ramniwas
Seema Ramniwas
In the current investigation, silver/gold nanoparticles (NPs) were synthesized using two methods: chemical and biological, and then characterized colloidal solutions of both NPs using UV-Vis, transmission electron microscopy (TEM) and zeta potential analyzers, X-ray powder diffraction (XRD), and energy dispersive X-ray (EDX) as well as the ToxTrak test for in vitro toxicity and antibacterial activity against Gram-positive bacteria (B. subtilis) and Gram-negative bacteria (E. coli). The plasmon peak of chemical synthesized silver NPs (CH-AgNPs) and gold NPs (CH-AuNPs) was observed at 414 and 530nm, respectively, while the sharp plasmon peak of biological synthesized silver NPs (Bio-AgNPs) and gold NPs (Bio-AuNPs) was observed at 410 and 525nm. Under transmission electron microscopy (TEM), the average sizes of CH-AgNPs and CH-AuNPs were 50.56 and 25.98nm, respectively. Bio-AgNPs and Bio-AuNPs, on the other hand, had average sizes of 25.25 and 16.65nm, respectively. The stability of NPs was also investigated using the zeta potential. The crystalline structure of AgNPs was confirmed through XRD, and EDX results confirm the element compositions. In the ToxTrak test, the toxic effect value/percentage inhibition (TEV/PI) was calculated. The results showed that CH-AgNPs have the highest TEV/PI value (85.45 for B. subtilis and 83.77 for E. coli) when compared to Bio-AgNPs (55.75 for B. subtilis and 54.42 for E. coli). CH-AuNPs, on the other hand, were 33.51 toxic to B. subtilis and 36.85 toxic to E. coli, compared to Bio-AuNPs, which were 23.36 toxic to B. subtilis and 24.46 toxic to E. coli. The antibacterial activity of Ag/Au NPs was tested and monitored; zone of inhibition (mm in diameter) against B. subtilis and E. coli, with the following pattern emerging: CH-AgNPs (24.80) had the highest antibacterial activity followed by Bio-AgNPs (22.80)CH-AuNPs (10.60)Bio-AuNPs (09.00), whereas the control sample (tetracycline antibiotic) revealed a 25.08mm, zone of inhabitation. Overall, Bio-AgNPs and Bio-AuNPs are the most effective pathogen-killing materials with the lowest toxicity. Our suggestion is that such materials instead of chemical synthesized NPs can be used to coat antibiotic drugs and could be a game-changer for the pharmaceutical industry in terms of effectively controlling the pathogenic bacteria.